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Introduction
Dynamic protein phosphorylation, mediated by a conserved co-
hort of protein kinases, controls the profound changes in cellu-
lar  organization  required  for  mitosis  and  cytokinesis  (Nigg, 
2001). Many of these kinases share a common activation mech-
anism involving phosphorylation of a threonine residue within 
the activation or T loop and binding to a coactivator protein 
(Fig. 1 A; Gold et al., 2006). These events promote the position-
ing of key residues required for the phosphotransfer reaction 
from ATP bound in the kinase active site to the acceptor residue 
in the substrate protein (Huse and Kuriyan, 2002). T-loop phos-
phorylation can be autocatalytic or mediated by an upstream   
kinase and generally increases kinase activity by several orders 
of magnitude (Adams, 2003). Recent studies on the activation 
of Aurora A exemplify the importance of T-loop phosphoryla-
tion as a regulatory mechanism (Bayliss et al., 2003; Eyers   
et al., 2003). Aurora A is localized to the centrosomes and spindle 
poles from late S phase throughout mitosis, which is consis-
tent with its function in organizing mitotic spindle formation   
(Glover et al., 1995; Giet et al., 2002). Localization to the spin-
dle is achieved through the association of Aurora A with its 
binding partner TPX2 (Kufer et al., 2002). Besides this target-
ing function, TPX2 is critically important for autocatalytic 
phosphorylation of threonine 288 in the T loop of Aurora A and, 
hence, Aurora A activation (Bayliss et al., 2003; Eyers et al., 
2003). Furthermore, TPX2 also prevents the dephosphorylation 
of this residue (Bayliss et al., 2003; Eyers et al., 2003). Other 
interaction partners of Aurora A, such as PAK1, Ajuba, and 
Bora, have also been reported to facilitate T288 phosphoryla-
tion, although the structural basis for these effects is not yet 
known (Hirota et al., 2003; Zhao et al., 2005; Hutterer et al., 
2006). Consistent with the function of Aurora A in spindle pole 
maturation  and  separation, T288-phosphorylated  and,  hence, 
activated Aurora A can be detected at the spindle poles (Ohashi 
et al., 2006). Several potential Aurora A substrates on mitotic 
spindles have been described previously, including the BimC 
family kinesin KIF11/Eg5 (Giet et al., 1999, 2002; Kinoshita   
et al., 2005). Because KIF11/Eg5 is critically required for spindle 
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any protein kinases are activated by a con-
served regulatory step involving T-loop phos-
phorylation.  Although  there  is  considerable 
focus  on  kinase  activator  proteins,  the  importance  of 
specific T-loop phosphatases reversing kinase activation 
has  been  underappreciated.  We  find  that  the  protein 
phosphatase  6  (PP6)  holoenzyme  is  the  major  T-loop 
phosphatase for Aurora A, an essential mitotic kinase. 
Loss of PP6 function by depletion of catalytic or regula-
tory subunits interferes with spindle formation and chro-
mosome alignment because of increased Aurora A activity. 
Aurora A T-loop phosphorylation and the stability of the 
Aurora A–TPX2 complex are increased in cells depleted 
of PP6 but not other phosphatases. Furthermore, purified 
PP6 acts as a T-loop phosphatase for Aurora A–TPX2 
complexes in vitro, whereas catalytically inactive mu-
tants cannot dephosphorylate Aurora A or rescue the 
PPP6C depletion phenotype. These results demonstrate a 
hitherto unappreciated role for PP6 as the T-loop phos-
phatase regulating Aurora A activity during spindle for-
mation and suggest the general importance of this form 
of regulation.
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both increasing activity toward true substrates and reducing ac-
tivity toward other phosphorylated proteins (Johnson et al., 1996; 
Hirano et al., 1997; Tóth et al., 2000; Terrak et al., 2004). To achieve 
a clearer understanding of the regulation of mitosis, it is therefore 
necessary to identify the specific phosphatase holoenzyme com-
plexes opposing the key mitotic kinases. The recent identification 
of specific protein phosphatase 1 (PP1) and PP2A complexes 
regulating chromosome condensation and sister chromatid co-
hesion, respectively, has highlighted the importance of local de-
phosphorylation of kinase substrates during mitosis (Kitajima   
et al., 2006; Tang et al., 2006; Vagnarelli et al., 2006). In this 
study, we focus on the kinases themselves. Using an unbiased 
two-stage screen of protein phosphatase subunits, we search for 
T-loop phosphatase activities important for normal mitosis.
pole separation and bipolar spindle formation, a potential up-
stream regulatory role for Aurora A coordinating KIF11/Eg5 
activity with that of other spindle assembly factors is an attrac-
tive model (Clarke and Zhang, 2008; Eckerdt et al., 2008).
Despite the recent advances in understanding how T-loop 
phosphorylation of the major mitotic kinases is accomplished 
(Gold et al., 2006), the opposing phosphatases remain largely 
elusive. The prevailing view is that dephosphorylation during 
mitosis is performed by phosphatase complexes of the phospho-
protein phosphatase (PPP) family (Bollen et al., 2009), making 
them good candidates for T-loop phosphatases. These enzymes 
consist of a catalytic subunit in complex with one or more regula-
tory subunits (Shi, 2009). The regulatory subunits confer local-
ization and substrate specificity to these holoenzyme complexes, 
Figure 1.  Identification of human phosphatases required for normal mitosis. (A) A model for the T loop–mediated kinase activation. Below is a schematic 
of the human protein phosphatase superfamily covering the phosphoprotein phosphatases (PPP), the metallophosphatases (PPM), and the phosphotyrosine 
protein (PTP) and dual-specificity phosphatases (DUSPs) modified from Chen et al. (2007). The number of phosphatase subunits screened in each sub-
family is indicated. (B) The screening procedure and the phenotypes expected are categorized using Roman numerals together with a brief description 
of the underlying causes. (C) HeLa cells were transfected with siRNA pools for 78 human phosphatase subunits, fixed after 48 h, and stained with DAPI 
to reveal the DNA and nuclear morphology. Abnormal nuclear morphology was scored according to the categories (I–V) described and is expressed as 
a histogram sorted from high to low (n = 3). The dotted line indicates twice the median value for nuclear abnormalities. For verification, HeLa cells were 
transfected with the four siRNA duplexes (06–09) making up the PPP6C siRNA pool, fixed after 48 h, and then stained with DAPI to reveal the DNA and 
nuclear morphology. Numbers in the top left corner correspond to the siRNA library pool used. Con., control. Bar, 10 µm.1317 Protein phosphates 6 regulates Aurora A • Zeng et al.
the pool were able to deplete PPP6C and cause the same altered 
nuclear morphology (Fig. 1 C, Western blot and bottom images). 
PP6 may therefore be a cell cycle regulator and a candidate T-loop 
phosphatase in human cells, and it was investigated further.
Analysis of the PP6 holoenzyme in mitosis
Like other PPP family members, PP6 is a multisubunit enzyme, 
comprising a single catalytic subunit and one of each of the 
three SIT4 phosphatase–associated protein (SAPS) domain   
regulatory subunits and three ankyrin repeat domain subunits   
(Stefansson and Brautigan, 2006; Stefansson et al., 2008). PP6 
also interacts with 4, which has a chaperone-like activity re-
quired to maintain active PP2A, PP4, and PP6 (Prickett and 
Brautigan, 2006; Kong et al., 2009). To define which of these 
subunits are important for mitosis, PP6 holoenzyme complexes 
were isolated from mitotic cells stably expressing FLAG-tagged 
PPP6C and then analyzed by SDS-PAGE and mass spectrome-
try. This revealed that HeLa cells express all known PP6 sub-
units and that these are present in PPP6C complexes during 
mitosis (Fig. 2 A). To test whether the PP6 SAPS domain regu-
latory subunits and ankyrin repeat domain subunits are required 
for normal mitosis, they were depleted using siRNA. Western 
blotting revealed that these subunits could be depleted singly or 
in combination, but this did not alter the amount of the PP6 cat-
alytic subunit present (Fig. 2 B). When all three SAPS domain 
regulatory subunits were depleted together, altered nuclear   
morphology similar to that seen after PPP6C depletion was   
observed (Fig. 2 C). Single depletions showed partially altered 
nuclear morphology (Fig. 2 C), supporting the idea that there   
is redundancy between these subunits. Depletion of the ANKRD52 
subunit had no effect on nuclear morphology, whereas ANKRD28 
and ANKRD44 ankyrin repeat subunit depletion altered nuclear 
morphology (Fig. 2 C). Collectively, these findings suggest that 
a PP6 holoenzyme, comprising PPP6C catalytic, SAPS1–3 regu-
latory, and ANKRD28–44 subunits, is required for normal mi-
totic progression.
PP6 activity is required for normal mitosis
The function of PP6 in mitosis could be explained by either a 
structural role or as an active phosphatase. To discriminate   
between these two possibilities, stable cell lines expressing   
either wild type (si08
ResPPP6C
WT) or catalytically inactive 
(si08
ResPPP6C
PD) mutant forms of the PP6 catalytic subunit were 
generated (Fig. 3 A). To enable depletion of the endogenous 
PP6 catalytic subunit, these constructs were engineered to be 
resistant to the PPP6C si08 duplex while retaining sensitivity to 
si07, to allow depletion of all PPP6C. When si08
ResPPP6C
WT 
cells were depleted of endogenous PPP6C using si08, the wild-
type transgene was able to rescue the phenotype, and cells re-
tained normal-shaped nuclei (Fig. 3 B). Depletion of all PPP6C 
using si07 gave the expected altered nuclear morphology.   
In contrast, when si08
ResPPP6C
PD cells were depleted of endog-
enous PPP6C using si08, the phosphatase-dead mutant trans-
gene was unable to rescue the phenotype, and cells displayed 
abnormally shaped nuclei similar to wild-type HeLa cells 
treated with the same duplex (Fig. 3 B). Depletion of endoge-
nous PPP6C by si07 and si08 and of the transgene-expressed 
Results
Identification of phosphatases required for 
normal mitosis
Loss of T-loop phosphatase function for the essential mitotic   
kinases should cause defective spindle formation, chromosome 
alignment, and cytokinesis and, therefore, give rise to cells with 
characteristic nuclear abnormalities (Fig. 1 B, stage 1). To iden-
tify nonredundant protein phosphatases required for normal   
mitosis, a visual screen for cells with abnormal nuclei after 48-h 
siRNA-mediated depletion of phosphatase subunits was per-
formed (Fig. 1, A–C). For this purpose, siRNA pools were used 
containing four different duplexes against the same target gene 
(Table S1). Of the phosphatase subunits tested, only seven gave 
rise to nuclear morphology defects with a frequency above a 
threshold set at twice the median value (Fig. 1 C). The most 
striking of these was the PP6 catalytic subunit (PPP6C), in which 
>70% of cells showed abnormally shaped fragmented nuclei 
but otherwise normal cell morphology (Fig. 1 C). Interestingly, 
a previous screen of phosphatases required for mitosis in Dro-
sophila melanogaster found that PP6 depletion caused a two-
fold  increase  in  the  mitotic  index,  but  its  function  was  not 
investigated further in this study (Chen et al., 2007). Mutations 
in PP6 were recently also found to cause spindle position and 
cell contractility defects in Caenorhabditis elegans early em-
bryonic cell divisions (Afshar et al., 2010). However, no sub-
strates  were  identified.  Of  the  other  phosphatase  subunits 
identified, PPP1R12A (MYPT1) has been reported to function 
as part of a PP1 holoenzyme complex in mitosis by opposing 
Plk1 (Yamashiro et al., 2008). Because the initial 48-h screen 
failed to pick the PP1 catalytic subunits, these were examined in 
more detail. At 72 h, the PPP1C-B catalytic subunit gave a nu-
clear  morphology  defect  similar  to  PPP1R12A  (Fig.  S1 A), 
which was consistent with previous findings that MYPT1 binds 
to PPP1C-B (Hartshorne et al., 2004; Yamashiro et al., 2008). 
Although  no  obvious  change  was  observed  with  PPP1C-A, 
PPP1C-C depletion resulted in alterations to the microtubule 
cytoskeleton  and  cell  shape  change  without  causing  nuclear   
abnormalities (Fig. S1 A), suggesting that PP1 catalytic subunits 
have distinct functions.
The PP2A regulatory subunit PPP2R5A was also found in 
the screen. PP2A regulatory (PPP2R5/B56/B isoform) and cat-
alytic subunits are present in the shugoshin complexes control-
ling centromeric cohesion (Kitajima et al., 2006). In this case, 
redundancy between the different PP2 catalytic subunits was 
observed (Fig. S1 B), explaining why they were not found in the 
initial screen. Depletion of both the A and B catalytic subunits 
of PP2A was necessary to cause cells to arrest in mitosis with 
scattered chromosomes (Fig. S1 B). Because the functions of 
PPP1R12A and PPP2R5A as part of PP1 and PP2A complexes, 
respectively, are already known (Kitajima et al., 2006; Yamashiro 
et al., 2008), it was therefore decided to focus on the category I 
phenotype seen with PPP6C.
To test whether the defect observed for PPP6C was both 
specific and indicative of a general function for this phosphatase 
in mitosis, additional verification steps were performed. When 
tested in isolation, all four of the single siRNA duplexes used in JCB • VOLUME 191 • NUMBER 7 • 2010   1318
Figure 2.  The PP6 holoenzyme is required for normal nuclear morphology. (A) PP6 complexes were purified from a cell line stably expressing PPP6C 
tagged at the C terminus with a FLAG epitope. The cells were arrested in mitosis using 200 ng/ml nocodazole for 18 h before cell lysis. The complexes 
were analyzed by mass spectrometry, SDS-PAGE, and Western blotting. Sequence coverage is based on the total number of peptides matching the protein 
found using Mascot, whereas peptide number is the number of peptides reported to be unique to this protein by MaxQuant and is thus a more stringent 
measure of identification for closely related proteins. (B and C) HeLa cells were transfected with control, SAPS, and ankyrin repeat domain siRNA duplexes 
alone or in combination for 48 h. The cells were Western blotted to verify depletion of the target proteins (B) or fixed and then stained with DAPI (shown), 
tubulin, and CREST antibodies (C). The graph shows the percentages of normal and micronucleated cells for the various conditions (n = 3). Molecular mass 
is given in kilodaltons. Error bars indicate the standard error of the mean. IP, immunoprecipitation. Bar, 10 µm.1319 Protein phosphates 6 regulates Aurora A • Zeng et al.
caused similar patterns of altered nuclear morphology and the 
formation of micronuclei (Fig. 4, A–C). The micronuclei over-
lap with a single puncta of CREST centromeric marker auto-
antiserum staining (Fig. 4, A and B). This indicates that they 
correspond to single chromosomes, possibly arising through de-
fects in chromosome segregation. To test whether the abnormal 
nuclei in PPP6C-depleted cells arise because of defective chro-
mosome alignment and segregation, HeLa (Fig. 4 D) or MRC-5 
(Fig. 4 E) cells were examined in mitosis. Control cells showed 
tightly aligned chromosomes in metaphase, which remain as 
well-defined masses as they segregate in anaphase and give rise 
to single nuclei in telophase (Fig. 4, D and E). In both cell lines 
tested, efficient PPP6C depletion resulted in poorly organized 
chromosome segregation in anaphase and in the formation of 
fragmented nuclei in telophase (Fig. 4, D and E). Similar effects 
form by si07 alone was verified by Western blotting (Fig. 3 B). 
Interestingly, the levels of transgene-expressed PPP6C increased 
when the endogenous PPP6C was depleted with si08 (Fig. 3 B), 
suggesting that the availability of the PP6 regulatory and an-
kyrin repeat subunits may be limiting for PPP6C stability under 
these conditions.
PP6 is required for timely  
spindle formation
Although the visual screen for defective nuclear morphology 
implicates PP6 in mitotic progression, it does not define the pro-
cess it functions in or, more importantly, what its substrates are. 
PP6 is localized to the cytoplasm (Fig. S2, A and B), giving little 
clue to its function. PPP6C depletion in either the HeLa cervical 
carcinoma cell line or MRC-5 human diploid lung fibroblasts 
Figure 3.  PP6 catalytic activity is required for normal nuclear morphology. (A) A schematic depicting the PP6 holoenzyme, PPP6C catalytic subunit, posi-
tions of siRNA duplexes used, and inactivating mutations. (B) HeLa cells stably expressing PPP6C si08–resistant wild-type (si08
ResPPP6C
WT) and phosphatase-
dead mutant (si08
ResPPP6C
PD) forms of PPP6C tagged at the C terminus with a FLAG epitope were transfected with control (siCon) or si07 and si08 duplexes 
targeting PPP6C for 48 h. The cells were Western blotted or fixed and then stained with DAPI, tubulin (Tub), and CREST antibodies. Abnormal nuclear 
morphology was scored for each condition and is plotted in the graph (n = 3). Molecular mass is given in kilodaltons. Error bars indicate the standard 
error of the mean. Bars, 10 µm.JCB • VOLUME 191 • NUMBER 7 • 2010   1320
Cold-stable kinetochore fiber microtubule bundles, although dis-
ordered, were also still present in PPP6C-depleted cells but lost   
in Nuf2-depleted cells (Fig. S3 B), in which the kinetochore   
attachment site is disrupted (DeLuca et al., 2002). In contrast,   
the centrosomes defined by pericentrin often failed to localize 
at the spindle poles in PPP6C-depleted cells (Fig. S3, B and C). 
The defects in efficient chromosome capture and alignment seen 
in the absence of PP6 function do not appear to be caused by 
unstable kinetochore fibers or gross kinetochore defects and 
could therefore be caused by misregulation of the centrosome-
mediated spindle formation pathway.
PP6 is an Aurora A T-loop phosphatase
To pursue the idea that PP6 is a mitotic regulator important for 
spindle formation, stage 2 of the screen was focused on the key 
kinase regulators of spindle formation from the centrosome   
Aurora A and Plk1 (Llamazares et al., 1991; Glover et al., 1995; 
Lane and Nigg, 1996; Roghi et al., 1998). If the T-loop phos-
phatase acting on either kinase is absent, the phosphorylated 
form will be stabilized under conditions in which dephosphory-
lation is normally favored over phosphorylation (Ahonen et al., 
2005; Daum and Gorbsky, 2006). This can be simply achieved 
were seen in cells depleted of all three SAPS domain proteins 
(Fig. 4 F). This supports the idea that the PP6 holoenzyme is re-
quired  for  normal  mitotic  progression.  Live-cell  imaging  of 
cells stably expressing EGFP-tagged histone H2B (Fig. 5 A) or 
mCherry-tagged  histone  H2B  and  EGFP-tagged  -tubulin   
(Fig. 5 B) revealed that PPP6C-depleted cells did not form a bi-
polar spindle with normal kinetics and failed to efficiently align 
their chromosomes at the metaphase plate. These cells also showed 
a prolonged arrest in mitosis (Fig. 5, A–C), during which time the 
chromosomes continuously tumbled about before eventually 
aligning to form a loose metaphase plate (Fig. 5, A and B; 
Video 1 and Video 2 show control and PPP6C-depleted cells, 
respectively). After an extended period, PPP6C-depleted cells 
formed bipolar spindles (Fig. 5 B). However, these were disordered 
compared with control cells. Biochemical analysis of thymidine-
synchronized cells depleted of PPP6C passing through mitosis 
revealed elevated levels of pT288-phosphorylated Aurora A and 
delayed passage through mitosis, as judged by the timing of 
cyclin B degradation (Fig. 5 D). These observations hinted at a 
defect in the pathway of spindle formation or chromosome cap-
ture. Examination of the PPP6C-depleted cells revealed no 
obvious changes in kinetochore or checkpoint proteins (Fig. S3 A). 
Figure 4.  Abnormal chromosome segregation in PPP6C-depleted cells. (A and B) HeLa (A) and MRC-5 (B) cells were transfected with control and PPP6C 
siRNA duplexes for 24–72 h. The cells were fixed and then stained with DAPI, tubulin (green), and CREST antibodies. Bars, 10 µm. (C) The same samples 
were also Western blotted to test for PPP6C depletion. Molecular mass is given in kilodaltons. (D and E) Control and PPP6C-depleted HeLa (D) and MRC-5 
(E) cells in anaphase and telophase are shown. (F) HeLa cells were transfected with all three SAPS domain siRNA duplexes for 72 h. The cells were fixed 
and then stained with DAPI, tubulin (green), and CREST antibodies. Cells in anaphase and telophase are shown. (D–F) Bars, 5 µm. In all panels, arrow-
heads mark lagging chromosomes, and these regions are shown in the inset enlargements.1321 Protein phosphates 6 regulates Aurora A • Zeng et al.
Figure 5.  Abnormal spindle formation in PPP6C-depleted cells. (A) HeLa cells stably expressing EGFP-tagged histone H2B were transfected with control 
or PPP6C si08 duplexes for 48 h and then imaged. An image stack of 25 planes spaced 0.7 µm apart was taken at four stage positions every minute for 
10–12 h. Exposure times were 10 ms for EGFP-tagged histone H2B using 1% of full lamp intensity. A brightfield reference image stack was also collected 
using 10-ms exposures. (B) HeLa cells stably expressing mCherry-tagged histone H2B and EGFP-tagged -tubulin were transfected for 48 h with control or 
PPP6C si08 duplexes and then imaged every minute at three stage positions for 10 h using a spinning-disk confocal microscope (Ultraview Vox). Laser set-
tings were 3% with 30-ms exposure per channel, and 35 optical sections spaced 0.5 µm apart were taken for both channels. Representative examples of 
cells passing through mitosis are shown. The times are given in hours and minutes. Arrowheads mark abnormal spindle poles and lagging chromosomes. 
(C) The time taken to form a spindle and pass through mitosis was measured from the live-cell imaging and is plotted in the graphs (40 cells from three 
experiments). A histogram of spindle formation is also shown with a graph showing the observed defects in chromosome alignment and spindle poles (38 
cells from three experiments). (D) HeLa cells were transfected with control or PPP6C si08 duplexes for 48 h. During the last 18 h, they were arrested with   
2 mM thymidine. After washout of the thymidine, samples were collected at the times indicated, split, and used for FACS analysis or Western blotting.   
Mitotic index calculated from the FACS analysis is shown below the Western blot at the corresponding time point. The graph shows the ratio of phosphorylated/ 
total Aurora A at each time point (n = 2). Where present, the red and black lines indicate the phosphorylated and nonphosphorylated forms of Aurora A. 
Molecular mass is given in kilodaltons. Error bars indicate the standard error of the mean. Bars, 10 µm.JCB • VOLUME 191 • NUMBER 7 • 2010   1322
Figure 6.  Identification of PP6 as the Aurora A T-loop phosphatase. (A) HeLa cells were transfected with siRNA pools for 72 human phosphatase subunits 
for 54 h, treated for 18 h with nocodazole, and then lysed in the absence of phosphatase inhibitors for 2 h on ice. Control samples were lysed in the pres-
ence or absence of phosphatase inhibitors (PP-Inh). Samples were Western blotted for total Aurora A and Aurora A pT288. The graph shows the ratio of 1323 Protein phosphates 6 regulates Aurora A • Zeng et al.
standard lysis procedures resulted in the loss of Aurora A phos-
phorylation in control cell lysates (Fig. 7 A, lanes 1–4). Consis-
tent with this, TPX2 did not interact with Aurora A under these 
conditions (Fig. 7 A, lane 6). Depletion of the PP6 catalytic sub-
unit using si08 or the addition of excess phosphatase inhibitors 
stabilized the upshifted form of Aurora A and its interaction 
with TPX2 (Fig. 7 A, compare lanes 8 and 9 with lanes 5 and 6). 
Kinase assays on these complexes showed that PPP6C deple-
tion stabilized Aurora A kinase activity toward TPX2 and the 
model substrate histone H3 under conditions in which it is lost 
in the control samples (Fig. 7 A, compare lane 9 with lane 6). 
Similarly, depletion of PPP6C using a second duplex, si07, or of 
the PP6 SAPS1/2/3 regulatory subunits stabilized the upshifted 
form of Aurora A and its interaction with TPX2 (Fig. 7 B, com-
pare lanes 7 and 8 with lanes 10 and 11 and 13 and 14). In contrast, 
depletion of PP2A or PP1 catalytic subunits did not stabilize   
either the upshifted pool of Aurora A or its interaction with TPX2 
(Fig. 7, C and D, compare lanes 7 and 8 or 20 and 21 with lanes 
10 and 11, 13 and 14, and 23 and 24). This is in agreement with 
previous findings that these phosphatases can only act on free 
Aurora A and not Aurora A in complex with TPX2 (Bayliss   
et al., 2003; Eyers et al., 2003).
To provide further evidence that PP6 acts directly on   
Aurora A–TPX2 complexes, phosphatase assays using purified 
proteins  were  performed. When Aurora A–TPX2  complexes 
were incubated with the catalytically active PP6 holoenzyme 
purified  from  mitotic  cells, Aurora A  was  dephosphorylated 
(Fig. 7 E, lane 2). This effect was not seen when buffer, catalyti-
cally inactive PP6, or a mock enzyme purification was used 
(Fig. 7 E, lanes 1, 3, and 4). The nonspecific phosphatase activ-
ity of calf intestinal phosphatase was unable to dephosphorylate 
Aurora A–TPX2 complexes under these conditions (Fig. 7 E, 
lane 5), which was consistent with previous observations that 
the  phosphorylated  T288  T-loop  residue  is  protected  in  the 
TPX2 complex. This suggests that PP6 specifically recognizes 
the Aurora A–TPX2 complex and gains access to the protected 
phosphorylated T288 residue (Bayliss et al., 2003). These ob-
servations are summarized in a model in which the PP6 holo-
enzyme acts on the Aurora A–TPX2 complex, whereas PP1 and 
PP2A act on free Aurora A (Fig. 7 F).
Aurora A inhibition rescues the PPP6C 
depletion phenotype
Previous studies have suggested that activated Aurora A in com-
plex with TPX2 accumulates at the spindle (Kufer et al., 2002; 
Bayliss et al., 2003; Eyers et al., 2003; Ozlü et al., 2005; Ohashi 
et al., 2006). Loss of PP6 function, which stabilizes the Aurora A–
TPX2 complex, should, therefore, result in increased levels of 
by cell lysis on ice for 2 h in the absence of phosphatase inhibi-
tors (outlined in Fig. 1 B, stage 2).
Cell lysates prepared from control or phosphatase sub-
unit–depleted cells were therefore Western blotted with anti-
bodies to Aurora A and the phosphorylated T288 T-loop residue 
(Ohashi et al., 2006). Because the visual screen indicated some 
redundancy between PP1 and PP2 catalytic subunits, these were 
depleted alone and in combination. As expected, Aurora A 
phosphorylation was lost during lysate preparation from control 
cells using standard lysis procedures without phosphatase in-
hibitors (Fig. 6 A, red bars). Notably, it was retained in PPP6C-
depleted cell lysates but not under the other conditions tested 
(Fig. 6 A, duplex 44), suggesting that PP6 is the major Aurora A 
T-loop phosphatase. This shift was more clearly seen on gels 
cast with the Phos-tag reagent (Fig. 6 B, duplex 44), which 
slows the mobility of phosphorylated proteins and, thus, better 
resolves  them  from  their  nonphosphorylated  counterpart.   
Several criteria suggest that Aurora A is a specific target of PP6. 
No other phosphatase tested stabilized the phosphorylated form 
of Aurora A (Fig. 6, A and B). Both the Aurora A pT288 signal 
and  the  upshifted  phosphorylated  form  of Aurora A  were   
protected after depletion of either the PP6 catalytic or SAPS 
regulatory subunits (Fig. 6, C and D, respectively), which was 
consistent with a requirement for the PP6 holoenzyme. Plk1 is 
phosphorylated on T210 (Jang et al., 2002), and, in contrast to 
Aurora A T288 phosphorylation, this was not altered by PP6 
catalytic or SAPS regulatory subunit depletion (Fig. 6, C and D). 
Levels of other phosphatases, such as PP1 and PP2, were un-
altered under these conditions (Fig. 6 C), suggesting altered 
Aurora A phosphorylation was primarily caused by the loss of 
PP6 activity. Addition of excess phosphatase inhibitor cocktail 
to the buffer stabilized Aurora A T288 phosphorylation and the 
upshifted form of Aurora A and revealed that there is slightly 
more T288-phosphorylated Aurora A in PP6 catalytic or regula-
tory subunit–depleted cells than in the control cells (Fig. 6,   
C and D). Depletion of the PP1 and PP2 catalytic subunits   
alone (Fig. 6 E) or in combination (Fig. 6 A) did not stabilize 
Aurora A phosphorylation. Together, these observations indicate 
that the PP6 holoenzyme comprising both catalytic and regula-
tory subunits is an Aurora A T-loop phosphatase and that the 
underlying defect after the loss of PP6 function is misregulation 
of Aurora A and not Plk1.
PP6 acts on the Aurora A–TPX2 complex
Activated Aurora A forms a complex with the spindle assembly 
factor TPX2 (Kufer et al., 2002; Bayliss et al., 2003; Eyers and 
Maller, 2004), and the effects of PP6 inactivation on the Aurora A–
TPX2 complex were therefore investigated. As already shown, 
phosphorylated/total Aurora A (n = 2). The red line indicates the median value for Aurora A phosphorylation. (B) HeLa cells were transfected with siRNA 
pools for 73 human phosphatase subunits for 54 h, treated for 18 h with nocodazole, and then lysed in the absence of phosphatase inhibitors for 2 h 
on ice. In addition, control and PPP6C-depleted samples were lysed in the presence or absence of phosphatase inhibitors. All samples were analyzed on 
Mn
2+ Phos-tag gels to better resolve phosphorylated from nonphosphorylated Aurora A and then Western blotted for total Aurora A and actin as a loading 
control. Red boxes highlight siRNA 44 (PPP6C) in which Aurora A phosphorylation is retained and an adjacent sample in which it is not. (C–E) HeLa cells 
were transfected for 48 h with control, PPP6C si08, SAPS1–3, PP1C A, PP1C B, PP1C C, and PP2C A siRNA duplexes. Lysates were then prepared from 
these cells in immunoprecipitation buffer containing or lacking phosphatase inhibitor cocktail and Western blotted. Graphs show phosphorylated Aurora A 
levels (n = 3). Molecular mass is given in kilodaltons. Error bars indicate the standard error of the mean. Where present, the red and black lines indicate 
the phosphorylated and nonphosphorylated forms of Aurora A. White lines indicate that intervening lanes have been spliced out.
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Figure 7.  PP6 catalytic or regulatory subunit depletion stabilizes the Aurora A–TPX2 complex. (A and B) TPX2–Aurora A complexes were isolated from 
control and PPP6C si08 (A) or control, PPP6C si07, or SAPS1–3-depleted (B) cell lysates prepared in the presence or absence of phosphatase inhibitors 
(PP-Inh.). GFP antibodies were used as a negative control (Con.). Total lysates and immune-precipitated (IP) material were Western blotted or used for kinase 
assays as indicated. White lines indicate that intervening lanes have been spliced out. (C and D) TPX2–Aurora A complexes were isolated from control, 
PP2C A–, and PP2C B–depleted (C) or control and PP1C A–, B–, and C–depleted (D) cell lysates prepared in the presence or absence of phosphatase 
inhibitors. Total lysates and immune-precipitated material were Western blotted. (E) Purified Aurora A–TPX2 complexes were incubated with wild-type or 
catalytically inactive recombinant PP6 holoenzymes, PP6
WT and PP6
PD, respectively, buffer, mock-purified enzyme, or 2.5 U of calf intestinal phosphatase 
(CIP) for 2 h and then Western blotted. The graph shows phosphorylated Aurora A levels (n = 2). Error bars indicate the standard error of the mean.   
(F) A model outlining the role of PP6 as an Aurora A–TPX2 phosphatase. PP1 and PP2A can act as free Aurora A phosphatases but cannot recognize   
the TPX2-complexed form that promotes spindle formation. Where present, the red and black lines indicate the phosphorylated and nonphosphorylated 
forms of Aurora A. Molecular mass is given in kilodaltons.1325 Protein phosphates 6 regulates Aurora A • Zeng et al.
In contrast, cells depleted of PPP6C failed to recruit Eg5 and 
NuMa to spindle poles in prophase (Fig. 9 A, siPPP6C). Prometa-
phase spindle poles were also highly fragmented and disordered 
(Fig. 9 A, siPPP6C), which was consistent with the results   
obtained by live-cell imaging, which showed delayed spindle 
formation and defective spindle integrity (Fig. 5 B). To allow a 
better measurement of this effect, cells were arrested in pro-
metaphase using the Eg5 inhibitor S-trityl-l-cysteine, and bipolar 
spindle formation followed after washout of the drug. In this   
assay, control cells rapidly formed a bipolar spindle within 15 min 
of drug washout, aligned their chromosomes, and entered ana-
phase by 60 min (Fig. 10, A and B). In contrast, PPP6C-depleted 
cells had a pronounced delay in both bipolar spindle formation 
and chromosome alignment (Fig. 10, A and B). This suggested 
that the spindle-associated activity of Eg5 and other spindle 
assembly  factors  may  be  limiting  in  PPP6C-depleted cells.   
In accordance with this idea, the spindle-associated level of 
both Eg5 and NuMa was reduced compared with control cells 
(Fig. 9 A and measured in Fig. S5). If this reduction was 
caused by unchecked Aurora A activity, Aurora A inhibition 
should reverse this effect. When PPP6C-depleted cells were 
treated with MLN8237 for 10 min to inhibit Aurora A, Eg5 local-
ization to the spindle recovered to the levels seen in control 
cells, and focused NuMa staining around the spindle poles was 
reinstated (Fig. 9 B, compare siPPP6C with siPPP6C + 10 µM 
MLN8237 conditions). Collectively, these findings support a 
model in which PP6 regulates spindle formation by limiting the 
activity of the Aurora A–TPX2 complex toward key spindle as-
sembly factors, including Eg5 and NuMa.
Discussion
PP6 is the Aurora A T-loop phosphatase
The findings reported here suggest that PP6 plays an important 
role during mitotic spindle formation. Specifically, PP6 is the   
T-loop phosphatase regulating Aurora A activity at the mitotic 
spindle. This may explain recent findings in C. elegans in which 
mutations in PP6 were found to cause mitotic defects in spin-
dle positioning and cortical contractility of the early embryo   
(Afshar et al., 2010). These findings add to the previously re-
ported functions of PP6 in S phase and nuclear factor–B sig-
naling (Stefansson and Brautigan, 2006; Mi et al., 2009; Douglas 
et al., 2010) and negative regulation of the Mis12 kinetochore 
protein in fission yeast (Goshima et al., 2003). Other PPP fam-
ily phosphatases have many functions at different stages of the 
cell cycle and in a variety of processes in nondividing cells, 
which can be explained by their many different isoforms com-
prised of a series of closely related subunits. It is reasonable to 
believe that this is also true for PP6 (Stefansson et al., 2008) and 
that specific isoforms are likely to have functions in S phase and 
M phase. The results presented here suggest that the ANKRD28 
and  44  subunits  are  required  for  PP6  function  in  mitosis, 
whereas ANKRD52 is not. Interestingly, ANKRD28 and 44 are 
most closely related, whereas ANKRD52 is less similar. This   
is intriguing because the MYPT1 ankyrin repeat subunit of PP1 
is important in substrate recognition (Tóth et al., 2000; Terrak   
et al., 2004). Therefore, the forms of PP6 important in mitosis 
activated Aurora A at the mitotic spindle. Consistent with the 
biochemical  changes,  PPP6C-depleted  cells  showed  altered 
staining at the spindle for activated Aurora A pT288 and the 
Aurora A activator TPX2 (Fig. S4, siPPP6C, arrowheads).   
In control cells, activated Aurora A pT288 and TPX2 staining 
was most predominant at the spindle poles with a faint staining 
spread along spindle microtubules (Fig. 8 A and Fig. S4, 
siControl). In PPP6C-depleted cells, the spindle microtubule 
staining of both activated Aurora A and TPX2 was increased 
(Fig. 8 A and Fig. S4, siPPP6C), and this could be reversed by a 
combined  PPP6C  and TPX2  depletion  (Fig.  S4,  siPPP6C  + 
TPX2). It was not possible to completely deplete TPX2, and a 
small amount always remained at centrosomes, where it over-
lapped with a population of activated Aurora A that was un-
altered by PPP6C depletion.
Highly specific small molecule inhibitors for Aurora fam-
ily kinases have recently been developed (Manfredi et al., 2007; 
Karthigeyan et al., 2010), and this suggested a rescue strategy 
for the PPP6C depletion phenotype. Low doses of Aurora A in-
hibitors were therefore tested to see whether they reversed the 
increased Aurora A activation and T-loop phosphorylation seen 
upon PPP6C depletion. Limiting titration of the Aurora A in-
hibitor MLN8237 did not block cell growth but reversed the   
effect of PPP6C depletion on Aurora A T-loop phosphorylation, 
with 10 nM MLN8237 resulting in the same ratio of activated to 
inactivated Aurora A seen in control cells in the absence of the 
drug (Fig. 8 A, gel image on bottom). Depletion of PPP6C re-
sulted in a twofold increase in the pT288 form of Aurora A at 
prometaphase and metaphase spindles compared with control 
cells, and addition of 10 nM MLN8237 reversed this increase 
(Fig. 8 A). Importantly, this partial Aurora A inhibition with   
10  nM  MLN8237  also  reduced  the  micronucleation  seen  in 
PPP6C-depleted cells from 40 to 5% (Fig. 8 B). Reduction of 
Aurora A activity using TPX2 depletion also rescued the PPP6C 
depletion nuclear morphology defect (Fig. 8 C), which was con-
sistent with the idea that TPX2 and PP6 have opposing effects 
on Aurora A activity. These results suggest that PPP6C deple-
tion results in unchecked activation of Aurora A caused by loss 
of the T-loop phosphatase activity and, thus, disturbs the fine 
balance of Aurora A–TPX2 complexes at the spindle required 
for chromosome capture and alignment. The reversal of the 
PPP6C phenotype by reduction of Aurora A activity using TPX2 
depletion or MLN8237 also indicates that Aurora A is a major 
substrate of PP6.
PP6 opposes Aurora A to control  
spindle formation
Aurora A, together with the Ran–importin pathway, is part of a 
complex regulatory system controlling the action of spindle as-
sembly factors, such as NuMa and TACC, and kinesin motor 
proteins, such as Eg5/KIF11, required to form a bipolar mitotic 
spindle (Giet et al., 1999, 2002; Tsai et al., 2003; Clarke and 
Zhang, 2008). The effect of PP6 inactivation by PPP6C deple-
tion on these spindle assembly factors was therefore investi-
gated. In control cells undergoing unperturbed mitosis, Eg5 and 
NuMa were recruited to the forming spindle poles in prophase 
and remained there until the onset of anaphase (Fig. 9 A, siControl). JCB • VOLUME 191 • NUMBER 7 • 2010   1326
Figure 8.  Aurora A inhibition rescues the PPP6C depletion phenotype. (A) HeLa cells transfected for 48 h with control and PPP6C si08 duplexes were 
treated with 10 or 20 nM MLN8237 or a solvent control for 15 min before lysis in phosphatase inhibitor containing buffer or fixation. Total lysates were 
analyzed by Western blotting. The red and black lines indicate the phosphorylated and nonphosphorylated forms of Aurora A. Fixed cells were stained 
using DAPI to detect DNA and antibodies to -tubulin and Aurora A pT288. The intensity of pT288 staining was integrated using ImageJ over the spindle 
region defined by TPX2 staining and is plotted in the bar graph (n = 4). Arrowheads indicate micronuclei. Bar, 5 µm. (B) HeLa cells transfected for 48 h with 
control and PPP6C si08 duplexes were treated with 10 nM MLN8237 or a solvent control for 24 h before fixation and staining with DAPI to detect DNA 1327 Protein phosphates 6 regulates Aurora A • Zeng et al.
from the bulk solution in the presence of TPX2. Here, we show 
that PP6 is a physiologically relevant T-loop phosphatase in   
human cells, which recognizes the active, TPX2-complexed form 
of Aurora A. This suggests that PP6 can access the buried pT288 
residue, possibly by altering the conformation of the Aurora A–
TPX2 complex. An intriguing possibility is that the Aurora A–
specific activator TPX2 also acts as a recognition determinant 
for the PP6 T-loop phosphatase. This would allow PP6 to spe-
cifically recognize and act upon the Aurora A–TPX2 complex.
Previous studies have reported that Aurora A can be   
dephosphorylated by PP1 or PP2A in vitro (Andrésson and   
Ruderman, 1998; Walter et al., 2000; Bayliss et al., 2003; Eyers 
et al., 2003; Tsai et al., 2003). However, this is prevented in the   
and S phase may have unique substrates determined by the 
ANKRD28/44 and 52 subunits, and this will be an important 
avenue for further investigation.
Exactly what constitutes a PP6 substrate recognition de-
terminant is unclear. In the future, it should be possible to define 
this determinant by comparing the mitotic PP6 substrate Aurora 
A and the closely related kinase Aurora B, which is not a sub-
strate (unpublished data). High quality crystal structures have 
been solved for both the Aurora A–TPX2 and the Aurora B– 
INCENP (inner centromere protein) complexes (Bayliss et al., 
2003; Sessa et al., 2005). These reveal that Aurora A pT288 is 
exposed to solvent in the absence of TPX2, reorients and hydro-
gen bonds with Aurora A–arginine 255, and, thus, is protected 
and CREST to mark centromeres. Micronucleation is quantitated in the graph (n = 3). (C) HeLa cells were transfected for 48 h with control, PPP6C si08, and 
TPX2 duplexes alone or in combination before fixation. Cells were stained using DAPI to detect DNA and CREST to mark centromeres. The graph shows the 
percentages of normal and micronucleated cells for the various conditions (n = 3). (B and C) Arrowheads indicate CREST staining outside the main nucleus 
defined by the DAPI staining. Bars, 10 µm. Molecular mass is given in kilodaltons. Error bars indicate the standard error of the mean.
 
Figure 9.  Spindle assembly factors are misregulated after PPP6C depletion. (A) HeLa cells were transfected for 48 h with control or PPP6C si08 duplexes 
before fixation. Cells were stained using DAPI to detect DNA and antibodies to -tubulin (Tub), Eg5, and NuMa. (B) Control and PPP6C-depleted cells 
treated with solvent (DMSO) or 10 µM MLN8237 for 10 min were fixed and then stained for Eg5, NuMa, tubulin (not depicted), and with DAPI to detect 
DNA. Bars, 10 µm. In both panels, KIF11/Eg5, NuMa, and tubulin signals were measured for the spindle region in ImageJ. KIF11/Eg5 and NuMa sig-
nals were normalized for tubulin and are plotted in the graph (n = 12). Error bars indicate the standard error of the mean. Arrowheads mark fragmented 
spindle poles.JCB • VOLUME 191 • NUMBER 7 • 2010   1328
Figure 10.  Bipolar spindle formation is delayed in PPP6C-depleted cells. (A) HeLa cells were transfected with control and PPP6C siRNA duplexes for   
48 h and then arrested overnight with S-trityl-l-cysteine to inhibit Eg5. The drug was washed out with fresh medium, and the cells were fixed at the time 
points indicated. Cells were stained with DAPI, tubulin (Tub), and pericentrin (Pctn) antibodies. Arrows mark the positions of pericentrin-positive centriole 
structures. Bar, 10 µm. (B) The spindle and chromosome alignment status of control and PPP6C-depleted cells was counted at the times indicated and is 
plotted in the graph (n = 4). Error bars indicate the standard error of the mean.1329 Protein phosphates 6 regulates Aurora A • Zeng et al.
cell death or sensitizes the cells to other mitotic poisons. Further 
work will be necessary to test these ideas, but preliminary data 
support this hypothesis (unpublished data). The strategy pre-
sented here is also likely to have general relevance for other 
classes of enzyme important for cell cycle control and cell sig-
naling pathways. Although it is notoriously difficult to identify 
enzyme substrates, the biochemical method used here provides 
a simple way to find the specific enzyme-catalyzing removal of 
any labile modification, such as phosphorylation, ubiquitylation, 
sumoylation, and others.
Materials and methods
Reagents and antibodies
Standard laboratory reagents were obtained from Thermo Fisher Scientific 
and Sigma-Aldrich. Antibodies to Eg5 (1–450 aa) were raised in sheep and 
rabbit using hexahistidine-tagged human proteins expressed in and purified 
from bacteria. Specific antibodies were purified using the antigens conjugated 
to Affigel-15. Commercially available antibodies were used to -tubulin 
(mouse DM1A; Sigma-Aldrich), Plk1 (mouse SC-17783; Santa Cruz Biotech-
nology, Inc.), Aurora A (rabbit AB12875; Abcam), Aurora A pT288 (rabbit 
3079; Cell Signaling Technology), PPP6C (rabbit A300-844A; Bethyl Labo-
ratories, Inc.), SAPS1–3 (rabbit A300-968A, A300-969A, and A300-972A; 
Bethyl Laboratories, Inc.), ANKRD28–52 (rabbit A300-974A and A302-
372A; Bethyl Laboratories, Inc.), CREST (human auto-antiserum; Europa 
Bioproducts Ltd.), KID (rabbit AKIN12-A; Cytoskeleton, Inc.), NuMa (mouse 
AB5673; Abcam), PP1- (rabbit 2582; Cell Signaling Technology), PP1- 
(rabbit A300-905A; Bethyl Laboratories, Inc.), PP1- (goat SC-6108; Santa 
Cruz  Biotechnology,  Inc.),  PP2A  (mouse  610555;  BD),  TPX2  (mouse 
ab32795;  Abcam),  Hec1  (mouse  GTX70268;  GeneTex,  Inc.),  CenpE 
(mouse ab5093; Abcam), CenpA (mouse ab13939; Abcam), pericentrin 
(rabbit ab4448; Abcam), and cyclin B1 (mouse GNS3; Millipore). Aurora A 
kinase inhibitor was obtained from Selleck Chemicals (MLN8237; 10 mM 
of 1,000,000× stock). Secondary antibodies raised in donkey to mouse, 
rabbit, sheep/goat, and human conjugated to HRP, Alexa Fluor 488, Alexa 
Fluor 555, Alexa Fluor 568, and Alexa Fluor 647 were obtained from Invit-
rogen and Jackson ImmunoResearch Laboratories, Inc.
Molecular biology
Full-length clones were amplified with the KOD polymerase (Merck) from 
total HeLa RNA extracted using TRIZOL (Invitrogen). Point mutations were 
introduced using the QuickChange system (Agilent Technologies) accord-
ing to the manufacturer’s protocol. All primers were obtained from Meta-
bion  GmbH.  Expression  constructs  were  produced  in  pcDNA3  vectors   
modified to encode the chicken -actin promoter to reduce expression   
levels, the required tags (EGFP, FLAG, or mCherry), and the geneticin,   
puromycin, or blasticidin resistance selection markers. The siRNA library 
targeting human phosphatase subunits and single duplexes corresponding 
to the individual pools were obtained from Thermo Fisher Scientific and are 
listed in Table S1.
Cell culture
HeLa and MRC-5 cells were cultured in growth medium (DME containing 
10% fetal bovine serum) at 37°C and 5% CO2. For plasmid transfection 
and siRNA transfection, LT1 (Mirus Bio, LLC) and Oligofectamine (Invitro-
gen), respectively, were used according to the manufacturer’s instruc-
tions. For making stable cell lines, constructs were transfected into HeLa 
S3 cells. After a 24-h selection, drugs were added as follows: 700 µg/ml 
geneticin, 1.0 µg/ml puromycin, and 2.0 µg/ml blasticidin. Colonies 
were  picked  after  a  14-d  selection,  and  expression  was  checked  by 
Western blotting.
Fixed and live-cell microscopy
Fixed samples on glass slides were imaged using a 60× 1.35 NA oil immer-
sion objective on a standard upright microscope system with filter sets for 
DAPI, EGFP/Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor 568, and Alexa 
Fluor 647 (Chroma Technology Corp.), a camera (CoolSNAP HQ2; Roper 
Industries), and imaging software (MetaMorph 7.5; Molecular Dynamics, 
Inc.). For live-cell imaging, cells were plated in 35-mm dishes with a 14-mm 
1.5 thickness coverglass window on the bottom (MatTek Corporation). For 
imaging, the dishes were placed in a 37°C and 5% CO2 environment   
Aurora A–TPX2 complex (Bayliss et al., 2003; Eyers et al., 
2003; Tsai et al., 2003), and, paradoxically, PP1 is therefore un-
able to act upon the active form of Aurora A. As shown here, 
PP6 is able to act on the Aurora A–TPX2 complex and does not 
suffer this limitation. PP6 is also the major Aurora A T-loop 
phosphatase activity in cell lysates, and PP1 contributes little, if 
any, activity consistent with the finding that PP1 is inactivated 
by inhibitory CDK1 phosphorylations in mitosis (Dohadwala, 
1994; Kwon, 1997). This raises the question of how PP6 has 
been overlooked until now. There may be three reasons for this. 
First, PP6 is inhibited by the toxins okadaic acid, microcystin-
LR, and calyculin A used to study PP1 and PP2A, and, depend-
ing on the model substrate used, is actually more sensitive than 
PP2A to these toxins (Prickett and Brautigan, 2006). In fact, the 
residues in PP2A required for very high affinity toxin binding 
are conserved in PP6, including the hydrophobic cage–forming 
residues glutamine 122 and histidine 191 (Xing et al., 2006). 
These residues are not conserved in PP1, explaining the reduced 
inhibition of PP1 by okadaic acid and microcystin-LR (Xing   
et al., 2006). Therefore, inhibitor studies do not unambiguously 
define which PPP family member is acting on a specific target. 
Second, inhibitor-2 (I-2) was previously used to implicate PP1 
as the Aurora A phosphatase (Tsai et al., 2003). However, it was 
subsequently shown that I-2 can directly stimulate Aurora A   
autophosphorylation activity (Satinover et al., 2004), suggesting 
that the effects of I-2 are independent of any inhibition of PP1. 
Third, previous studies have used the commercially available 
trypsin-resistant catalytic fragment of PP1, which lacks the reg-
ulatory subunits and, therefore, does not have the same substrate 
specificity as the PP1 holoenzyme (Johnson et al., 1987; Tóth   
et al., 2000; Terrak et al., 2004). The high degree of similarity in 
PPP family catalytic subunits also means that in the absence of 
regulatory subunits they will have limited specificity (Xing   
et al., 2006). Fitting with this view, catalytic subunits alone of 
either PP1 or PP2A can dephosphorylate free Aurora A (Bayliss 
et al., 2003; Eyers et al., 2003; Tsai et al., 2003).
Aurora A and PP6 in cancer
Finally, our findings have relevance beyond the biochemistry 
and cell biology of Aurora A regulation. Aurora A is amplified 
in many cancers and is currently the focus of much interest as a 
drug target for cancer therapy (Sen et al., 1997; Bischoff et al., 
1998; Zhou et al., 1998; Karthigeyan et al., 2010). Intriguingly, 
PPP6C is mutated at an absolutely conserved histidine lying 
within the catalytic site in melanoma (Bamford et al., 2004; 
Forbes et al., 2010). As we show here, loss of PP6 function will 
lead to increased Aurora A activity similar to the effects of   
Aurora A amplification. PPP6C could therefore be considered   
a novel tumor suppressor gene. Recent work suggests that the 
mitotic machinery is an Achilles’ heel for cancer cells carrying 
mutant Ras (Luo et al., 2009), and innovative ways of targeting 
key mitotic regulators are therefore of great interest. Our work 
suggests additional ways in which Aurora A activity can be tar-
geted through inactivation of PP6. PP6 inhibitors may be useful 
for targeting cancers with amplified or in some other way per-
turbed Aurora A activity. Under these conditions, PP6 inhibition 
might push the system into a runaway state that directly promotes JCB • VOLUME 191 • NUMBER 7 • 2010   1330
5-cm × 180-µm trap column (BEH-C18 Symmetry; Waters Corporation) in 
0.1% formic acid at 15 µl/min and then resolved using a 25-cm × 75-µm 
column using a 20-min linear gradient of 0 to 37.5% acetonitrile in 0.1% 
formic acid at a flow rate of 400 nl/min. The mass spectrometer was set 
to acquire a mass spectrometry survey scan in the Orbitrap (resolution = 
30,000) and then perform tandem mass spectrometry on the top five mul-
tiply charged ions in the linear quadrupole ion trap after fragmentation 
using collision ionization (30 ms at 35% energy). A 90-s rolling exclusion 
list with n = 3 was used to limit redundant analysis. Maxquant and Mascot 
(Matrix Science) were then used to compile and search the raw data 
against the human international protein index database. Protein group 
and peptide lists were sorted and analyzed in Excel (Microsoft) and Max-
quant (Cox and Mann, 2008). Mass spectrometry and tandem mass spec-
trometry spectra were manually inspected using Xcalibur Qualbrowser 
(Thermo Fisher Scientific).
Online supplemental material
Fig.  S1  shows  that  there  is  redundancy  between  protein  phosphatase 
catalytic subunits during mitosis. Fig. S2 shows that the subunits of the 
PP6 holoenzyme localize to the cytosol. Fig. S3 shows that kinetochore 
proteins localize normally and cold-stable kinetochore fibers are still pres-
ent in PPP6C-depleted cells. Fig. S4 shows increased Aurora A pT288 
at the spindle in PPP6C-depleted cells. Fig. S5 shows reduced levels of 
KIF11/Eg5 at the spindle in the absence of PPP6C. Videos 1 and 2 show 
the effect of PPP6C depletion on spindle formation and chromosome align-
ment in living cells. Table S1 contains a list of the siRNA duplexes directed 
toward phosphatase catalytic and regulatory subunits used in the course 
of this study. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201008106/DC1.
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chamber on the microscope stage. Imaging was performed using a 60× 
1.4 NA oil immersion objective on a standard inverted microscope under 
the control of MetaMorph 7.5 software or a spinning-disk confocal system 
(Ultraview Vox; PerkinElmer). A maximum intensity projection of the fluorescent 
channels was performed. Images were then cropped in ImageJ (National 
Institutes of Health) and placed into Illustrator CS3 (Adobe Systems, Inc.) to 
produce the figures.
Isolation of PP6 complexes
Wild-type and catalytically inactive PP6 complexes were isolated from 3 × 
15–cm dishes of si08
ResPPP6C
WT, si08
ResPPP6C
PD stable HeLa cell lines, or 
untransfected control cells grown to 60% confluence. The cells were ar-
rested in mitosis with 100 ng/ml nocodazole for 16 h. Mitotic cells were 
harvested by shake off, washed three times with warm PBS, and then resus-
pended in warm growth medium. The cells were incubated in a 5% CO2 
incubator at 37°C for 20 min and then washed twice with cold PBS. The 
cells were lysed in 1 ml of cell lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, and 1% Triton X-100 with protease inhibitor cocktail), left on ice for 
20 min, and then centrifuged at 20,000 gav for 20 min at 4°C to remove 
insoluble debris. To isolate PP6 complexes, 20 µl mouse anti-FLAG M2 
agarose beads (A2220; Sigma-Aldrich) were added into 900 µl of cell ly-
sate and rotated at 4°C for 3 h. The beads were washed with cell lysis buffer, 
and the PP6 complex was eluted with 2× 70 µl of 200 µg/ml FLAG peptide 
in TBS, pH 7.5, to give E1 and E2 fractions.
Phosphatase and kinase assays
Aurora A–TPX2 complexes for use as a substrate in in vitro phosphatase 
assays were prepared as follows from 3 x 15–cm dishes of HeLa cells 
grown to 60% confluence. Cell lysates were prepared as for PP6 isolation 
except that buffers contained phosphatase inhibitor cocktail 1 (Sigma- 
Aldrich). For Aurora A complex isolation, 2 µg mouse anti-TPX2 antibody 
and 60 µl protein G–Sepharose beads were added to 700 µl of cell lysate, 
and the mixture was rotated at 4°C for 2 h. The beads were washed with 
lysis buffer and then TBS and aliquoted into five tubes. To each tube, either 
20 µl TBS, E1-eluted si08
Res PPP6C
WT or si08
ResPPP6C
PD complex, E1-eluted 
HeLa control, or TBS with 0.5 µl of calf intestinal phosphatase was added. 
The tubes were incubated at room temperature for 2 h and then boiled for 
5 min at 95°C after adding 20 µl of 3× SDS loading buffer. Samples were 
analyzed by Western blotting on normal gels or gels containing 50 µM 
Phos-tag reagent (Wako Chemicals USA, Inc.) charged with Mn
2+ to better 
resolve phosphorylated from nonphosphorylated forms of the same pro-
tein. Quantitations were performed using ImageJ from blots of normal gels 
because reduced transfer efficiency of phosphorylated relative to non-
phosphorylated forms of the same protein from Phos-tag gels was observed.
For in vivo phosphatase assays, 5 × 10–cm dishes of HeLa cells 
were transfected with control or PPP6C si08 duplexes for 48 h and then 
treated with 100 ng/ml nocodazole for 16 h. Cells were harvested and 
lysed as for PP6 complex purification, except that the sample was split into 
two aliquots, one containing phosphatase inhibitor cocktail 1 and the other 
without. Cell lysis was left to proceed on ice for 20 min, and then insoluble 
debris was removed by centrifugation at 20,000 gav for 20 min at 4°C.   
A 30-µl aliquot of supernatant was kept on ice as an input sample, and   
Aurora A–TPX2 complexes were immune precipitated from the remaining   
lysate as described in the previous paragraph. The samples were analyzed 
by Western blotting, and measurements were performed using ImageJ. For 
phosphatase subunit siRNA library screening assays, this procedure was 
scaled down to use individual wells of a 6-well plate, and only cell lysates 
were analyzed.
For in vitro kinase assays, a modification of a published method 
was used (Preisinger et al., 2005). Control or Aurora A–TPX2 complexes 
isolated from 1.6 × 10
6 cells were incubated in 50 mM Tris-HCl, pH 7.3, 
50 mM KCl, 10 mM MgCl2, 20 mM -glycerophosphate, 15 mM EGTA, 
100 µM ATP, 0.5 µl -[
32P]ATP, and 1 µg histone H3 substrate in 20 µl of 
final volume for 30 min at 30°C. Reactions were analyzed by SDS-PAGE 
and autoradiography.
Mass spectrometry
Protein samples for mass spectrometry were separated on 4–12% gradi-
ent NuPAGE gels and then stained using a colloidal Coomassie blue stain. 
Gel lanes were cut into 12 slices and then digested with trypsin (Wilm   
et al., 1996). The resulting tryptic peptide mixtures in 0.05% trifluoroacetic 
acid were then analyzed by online liquid chromatography with tandem 
mass spectrometry with a nanoAcquity UPLC system (Waters Corporation) 
and a mass spectrometer (Orbitrap XL ETD; Thermo Fisher Scientific) fitted 
with a nanoelectrospray source (Proxeon). Peptides were loaded onto a 1331 Protein phosphates 6 regulates Aurora A • Zeng et al.
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